27.21
price down icon1.27%   -0.35
after-market アフターアワーズ: 27.20 -0.01 -0.04%
loading
前日終値:
$27.56
開ける:
$27.42
24時間の取引高:
870.48K
Relative Volume:
0.84
時価総額:
$1.62B
収益:
$66.05M
当期純損益:
$-422.60M
株価収益率:
-3.7526
EPS:
-7.251
ネットキャッシュフロー:
$-384.73M
1週間 パフォーマンス:
+9.72%
1か月 パフォーマンス:
-22.70%
6か月 パフォーマンス:
-32.83%
1年 パフォーマンス:
-9.21%
1日の値動き範囲:
Value
$26.93
$28.00
1週間の範囲:
Value
$25.65
$28.82
52週間の値動き範囲:
Value
$22.24
$46.00

Agios Pharmaceuticals Inc Stock (AGIO) Company Profile

Name
名前
Agios Pharmaceuticals Inc
Name
セクター
Healthcare (1106)
Name
電話
617-649-8600
Name
住所
88 SIDNEY STREET, CAMBRIDGE, MA
Name
職員
540
Name
Twitter
@AgiosPharma
Name
次回の収益日
2026-04-29
Name
最新のSEC提出書
Name
AGIO's Discussions on Twitter

Compare AGIO vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
AGIO icon
AGIO
Agios Pharmaceuticals Inc
27.21 1.64B 66.05M -422.60M -384.73M -7.251
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 109.34B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 74.35B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 50.44B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 39.78B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.02B 5.36B 287.73M 924.18M 2.5229

Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-20 繰り返されました H.C. Wainwright Buy
2025-11-24 開始されました Truist Buy
2025-11-20 アップグレード Leerink Partners Market Perform → Outperform
2025-11-19 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-02-24 開始されました H.C. Wainwright Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-10-10 再開されました Raymond James Outperform
2024-09-27 ダウングレード Leerink Partners Outperform → Market Perform
2024-02-08 開始されました Cantor Fitzgerald Overweight
2023-02-03 開始されました Piper Sandler Overweight
2022-11-17 アップグレード Goldman Sell → Neutral
2022-07-27 アップグレード SVB Leerink Mkt Perform → Outperform
2021-12-03 開始されました BofA Securities Buy
2021-07-30 ダウングレード Goldman Neutral → Sell
2021-07-01 開始されました Raymond James Mkt Perform
2021-06-10 開始されました H.C. Wainwright Buy
2021-03-01 ダウングレード JP Morgan Overweight → Neutral
2021-03-01 アップグレード SVB Leerink Mkt Perform → Outperform
2021-02-26 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-10-22 アップグレード Barclays Equal Weight → Overweight
2020-03-04 開始されました Barclays Equal Weight
2019-11-26 開始されました Cantor Fitzgerald Overweight
2019-09-23 アップグレード Guggenheim Neutral → Buy
2019-05-23 再開されました Goldman Neutral
2019-02-15 アップグレード SVB Leerink Mkt Perform → Outperform
2018-09-25 開始されました Leerink Partners Mkt Perform
2018-05-23 開始されました Citigroup Buy
2018-04-11 繰り返されました Credit Suisse Outperform
2018-02-15 繰り返されました Needham Buy
2018-02-15 繰り返されました SunTrust Buy
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-08-10 繰り返されました Needham Buy
2017-08-08 繰り返されました SunTrust Buy
2017-08-02 アップグレード Leerink Partners Mkt Perform → Outperform
2017-06-26 ダウングレード Janney Buy → Neutral
2017-01-17 アップグレード Oppenheimer Perform → Outperform
2016-10-24 開始されました Needham Buy
2016-06-13 アップグレード JP Morgan Neutral → Overweight
2016-05-18 繰り返されました SunTrust Buy
すべてを表示

Agios Pharmaceuticals Inc (AGIO) 最新ニュース

pulisher
May 04, 2026

Need To Know: Analysts Are Much More Bullish On Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Revenues - 富途牛牛

May 04, 2026
pulisher
May 04, 2026

AGIO beats on Q1 earnings & sales, stock up 13% on new drug momentum - MSN

May 04, 2026
pulisher
May 03, 2026

Agios Pharmaceuticals Stock Rises 11.2% on Strong Q1 2026 Aqvesme Launch and Pipeline Progress - IndexBox

May 03, 2026
pulisher
May 03, 2026

Agios Pharmaceuticals (AGIO) Is Up 11.2% After Rare Disease Launch And FDA Acceleration NewsHas The Bull Case Changed? - Sahm

May 03, 2026
pulisher
May 02, 2026

Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026) - The Motley Fool

May 02, 2026
pulisher
May 01, 2026

RBC Capital Sticks to Its Hold Rating for Agios Pharma (AGIO) - The Globe and Mail

May 01, 2026
pulisher
May 01, 2026

MSN Money - MSN

May 01, 2026
pulisher
May 01, 2026

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2026 Earnings Call Transcript - Insider Monkey

May 01, 2026
pulisher
May 01, 2026

Agios Pharmaceuticals Hits Day High with 13.1% Surge in Stock Price - Markets Mojo

May 01, 2026
pulisher
Apr 30, 2026

Agios Pharmaceuticals Reports 20.7 Million Dollars in Q1 Revenue - HarianBasis.co

Apr 30, 2026
pulisher
Apr 30, 2026

AGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug Momentum - The Globe and Mail

Apr 30, 2026
pulisher
Apr 30, 2026

Agios (AGIO) Q1 2026 Earnings Call Transcript - AOL.com

Apr 30, 2026
pulisher
Apr 30, 2026

AGIO Maintained by Truist Securities -- Price Target Lowered to $36 - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Truist Financial Issues Pessimistic Forecast for Agios Pharmaceuticals (NASDAQ:AGIO) Stock Price - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Agios Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

Apr 30, 2026
pulisher
Apr 30, 2026

(AGIO) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Apr 30, 2026
pulisher
Apr 30, 2026

Agios Pharmaceuticals Inc (AGIO) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and Strategic Advances - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals and other big stocks moving higher on Tuesday - MSN

Apr 30, 2026
pulisher
Apr 29, 2026

AGIO SEC FilingsAgios Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:AGIO) 2026-04-29 - Seeking Alpha

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals Q1 2026 Earnings Call Transcript - MarketBeat

Apr 29, 2026
pulisher
Apr 29, 2026

Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday - Yahoo Finance

Apr 29, 2026
pulisher
Apr 29, 2026

Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday - The Motley Fool

Apr 29, 2026
pulisher
Apr 29, 2026

Agios plans Q2 sNDA filing for mitapivat in sickle cell disease while citing >$10B 2030 market opportunity - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

Earnings Call Summary | Agios Pharmaceuticals(AGIO.US) Q1 2026 Earnings Conference - 富途牛牛

Apr 29, 2026
pulisher
Apr 29, 2026

Vanguard Capital Management (NASDAQ: AGIO) reports 3.09M shares, 5.27% ownership - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals (NASDAQ:AGIO) Releases Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals Releases Q1 2026 Financial Results - AlphaStreet

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals : 2026 Proxy Statement (a7ac5c) - marketscreener.com

Apr 29, 2026
pulisher
Apr 29, 2026

AGIO Financials: Income Statement, Balance Sheet & Cash Flow | Agios Pharmaceuticals Inc - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals Q1 2026 Financial Results: Net Loss, Revenue, and Key Financial Statements - Minichart

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Up on Earnings Beat - MarketBeat

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals reports $20.7M revenue, $(1.69) EPS on 10-Q - TradingView

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals (NASDAQ: AGIO) grows Q1 2026 sales while funding deep rare-disease pipeline - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Earnings call transcript: Agios Q1 2026 earnings soar past expectations By Investing.com - Investing.com Canada

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Reports Strong Q1 Revenue Growth and Strategic Advances - GuruFocus

Apr 29, 2026
pulisher
Apr 29, 2026

Q1 2026 Agios Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals (NASDAQ:AGIO) Q1 2026 Earnings Beat Drives Stock Rally - ChartMill

Apr 29, 2026
pulisher
Apr 29, 2026

Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q1 Net Loss $1.69 a Share, vs. FactSet Est of $1.80 Loss - marketscreener.com

Apr 29, 2026
pulisher
Apr 29, 2026

Earnings Flash (AGIO) Agios Pharmaceuticals, Inc. Reports Q1 Revenue $20.7M, vs. FactSet Est of $13.3M - marketscreener.com

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals: Q1 Earnings Snapshot - marketscreener.com

Apr 29, 2026
pulisher
Apr 29, 2026

Agios (NASDAQ: AGIO) doubles mitapivat revenue and funds 2026 pipeline catalysts - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

New thalassemia drug writes 242 U.S. scripts as Agios plans sickle cell filing - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Here's why Agios Pharmaceuticals stock slumped this week (and what investors have to look forward to in 2026) - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

Agios Pharmaceuticals (AGIO) Heavy EPS Loss Tests Growth‑Led Bullish Narratives Heading Into Q1 2026 - Sahm

Apr 29, 2026
pulisher
Apr 28, 2026

Agios Pharmaceuticals Q1 2026 earnings preview - MSN

Apr 28, 2026
pulisher
Apr 27, 2026

Q3 2025 Agios Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

Apr 27, 2026

Agios Pharmaceuticals Inc (AGIO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):